JAGSONPAL PHARMACEUTICALS
Back to Income Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹269 Cr | ₹209 Cr | ₹237 Cr | ₹218 Cr | ₹188 Cr |
What is the latest Revenue of JAGSONPAL PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹209 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹218 Cr |
| Mar2021 | ₹188 Cr |
How is Revenue of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | 28.76 | |
| Mar2024 | ₹209 Cr | -11.83 | |
| Mar2023 | ₹237 Cr | 8.79 | |
| Mar2022 | ₹218 Cr | 15.77 | |
| Mar2021 | ₹188 Cr | - | |
Compare Revenue of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,594.6 Cr | 5.1% | 5.4% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | 5.1% |
5.4% |
-3.5% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses